These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 22650261
1. Protein-protein interactions: network analysis and applications in drug discovery. Bultinck J, Lievens S, Tavernier J. Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261 [Abstract] [Full Text] [Related]
2. In silico structure-based approaches to discover protein-protein interaction-targeting drugs. Shin WH, Christoffer CW, Kihara D. Methods; 2017 Dec 01; 131():22-32. PubMed ID: 28802714 [Abstract] [Full Text] [Related]
3. Identification of inhibitors of Bcl-2 family protein-protein interaction by combining the BRET screening platform with virtual screening. Park IS, Seo HR, Kim K, Lee H, Shum D, Choi I, Kim J. Biochem Biophys Res Commun; 2020 Jun 30; 527(3):709-715. PubMed ID: 32423828 [Abstract] [Full Text] [Related]
4. Assessment of high-confidence protein-protein interactome in yeast. Karagoz K, Arga KY. Comput Biol Chem; 2013 Aug 30; 45():1-8. PubMed ID: 23608186 [Abstract] [Full Text] [Related]
5. Benchmark Study Based on 2P2IDB to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors. Wang Z, Kang Y, Li D, Sun H, Dong X, Yao X, Xu L, Chang S, Li Y, Hou T. J Phys Chem B; 2018 Mar 08; 122(9):2544-2555. PubMed ID: 29420886 [Abstract] [Full Text] [Related]
9. Using fragment-based technologies to target protein-protein interactions. Bower JF, Pannifer A. Curr Pharm Des; 2012 Mar 08; 18(30):4685-96. PubMed ID: 22650253 [Abstract] [Full Text] [Related]
10. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery? Thiel P, Kaiser M, Ottmann C. Angew Chem Int Ed Engl; 2012 Feb 27; 51(9):2012-8. PubMed ID: 22308055 [Abstract] [Full Text] [Related]
11. Databases of protein-protein interactions and their use in drug discovery. Fuentes G, Oyarzabal J, Rojas AM. Curr Opin Drug Discov Devel; 2009 May 27; 12(3):358-66. PubMed ID: 19396737 [Abstract] [Full Text] [Related]
12. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data. Sugaya N, Ikeda K, Tashiro T, Takeda S, Otomo J, Ishida Y, Shiratori A, Toyoda A, Noguchi H, Takeda T, Kuhara S, Sakaki Y, Iwayanagi T. BMC Pharmacol; 2007 Aug 20; 7():10. PubMed ID: 17705877 [Abstract] [Full Text] [Related]
15. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery. Murakami Y, Tripathi LP, Prathipati P, Mizuguchi K. Curr Opin Struct Biol; 2017 Jun 20; 44():134-142. PubMed ID: 28364585 [Abstract] [Full Text] [Related]
16. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder. Fu Y, Guo Y, Wang Y, Luo J, Pu X, Li M, Zhang Z. Comput Biol Chem; 2015 Jun 20; 56():41-8. PubMed ID: 25854804 [Abstract] [Full Text] [Related]
17. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area. Ran X, Gestwicki JE. Curr Opin Chem Biol; 2018 Jun 20; 44():75-86. PubMed ID: 29908451 [Abstract] [Full Text] [Related]
19. Protein-protein interaction networks as miners of biological discovery. Wang S, Wu R, Lu J, Jiang Y, Huang T, Cai YD. Proteomics; 2022 Aug 20; 22(15-16):e2100190. PubMed ID: 35567424 [Abstract] [Full Text] [Related]
20. High-quality binary protein interaction map of the yeast interactome network. Yu H, Braun P, Yildirim MA, Lemmens I, Venkatesan K, Sahalie J, Hirozane-Kishikawa T, Gebreab F, Li N, Simonis N, Hao T, Rual JF, Dricot A, Vazquez A, Murray RR, Simon C, Tardivo L, Tam S, Svrzikapa N, Fan C, de Smet AS, Motyl A, Hudson ME, Park J, Xin X, Cusick ME, Moore T, Boone C, Snyder M, Roth FP, Barabási AL, Tavernier J, Hill DE, Vidal M. Science; 2008 Oct 03; 322(5898):104-10. PubMed ID: 18719252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]